Aristeidis Chaidos

Imperial College Healthcare NHS Trust — United Kingdom

Medicine · Health Sciences

31h-index4.2kcitations159works0.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(45), Chronic Lymphocytic Leukemia Research(24), Protein Degradation and Inhibitors(23), Lymphoma Diagnosis and Treatment(14), Acute Myeloid Leukemia Research(13)

Publications155 total

Supplemental Figure from A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
2025Open Access
Supplementary Data1 from A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
2025Open Access
Supplementary Data1 from A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
2025Open Access
Randomized phase II dose optimization study of inobrodib (CCS1477), in combination with pomalidomide and dexamethasone in relapsed/refractory multiple myeloma (RRMM)
Blood·2025Open Access
Enhanced VLA4-dependent endothelial cell adhesion underpins the higher efficacy of CAR-iNKT over CAR-T cells in limiting leptomeningeal acute leukemia
Blood·2025Open Access
Cancer-selective targeting of the NF-κB pathway via GADD45β/MKK7 inhibition: Results from the phase I trial of the first-in-class inhibitor, DTP3, in patients with relapsed or refractory multiple myeloma
Blood·2025Open Access
Revealing oncogenic enhancer regulation by epigenomic profiling of multiple myeloma and plasma cell leukemia patient samples
Blood·2025Open Access
CXXC1 is required for IRF4 chromatin binding and expression and regulates cellular fitness in lenalidomide-sensitive and -resistant myeloma cells
Blood·2025
Evaluating inobrodib (CCS1477) in combination with teclistamab or elranatamab in patients with Relapsed/Refractory multiple myeloma; Specific cohorts within a Phase I/IIa study evaluating inobrodib in patients with advanced hematological malignancies
Blood·2025
Patient-reported outcomes with belantamab mafodotin, pomalidomide, and dexamethasone versus bortezomib, pomalidomide, and dexamethasone in patients with relapsed or refractory multiple myeloma (DREAMM-8): a phase 3, open-label, randomised controlled trial
The Lancet Haematology·2025· 1 cited
Parameters Associated With Renal Recovery and Survival in Myeloma Patients With Acute Renal Failure to Cast Nephropathy
American Journal of Hematology·2025· 2 citedOpen Access
Enhancing the iNKT cell immunotherapy platform by combining optimised CAR endodomains with novel iNKT engagers
2025Open Access
Multiple Myeloma
WORLD SCIENTIFIC (EUROPE) eBooks·2025
Diagnosis and management of monoclonal gammopathy of renal significance: A British Society for Haematology good practice paper
British Journal of Haematology·2025· 4 citedOpen Access
An International Study of 343 Newly Diagnosed MM Patients with Acute Renal Failure Due to Cast Nephropathy: Assessment of Factors Affecting Renal Response
Blood·2024Open Access
Curation of myeloma observational study MALIMAR using XNAT: solving the challenges posed by real-world data
Insights into Imaging·2024· 1 citedOpen Access
Immune Graft Composition Is Important for Deepening Response and Outcome after Autologous Stem Cell Transplantation in Patients with Multiple Myeloma Who Do Not Receive Maintenance Therapy
Blood·2023
Development of Novel Invariant TCR-Anchored Bispecific Engagers to Enhance Anti-Cancer Activity of iNKT Cells
Blood·2023· 2 cited
Optimal, Off-the-Shelf, CAR-iNKT Cell Platform-Based Immunotherapy for Multiple Myeloma
Blood·2023· 1 citedOpen Access
Supplementary Data1 from A Phase I/II Open-Label Study of Molibresib for the Treatment of Relapsed/Refractory Hematologic Malignancies
2023Open Access
page 1 of 8Next →

Frequent Co-authors

Anastasios Karadimitris(22), Irene Roberts(13), Jane F. Apperley(11), Amin Rahemtulla(10), Konstantinos L. Bourantas(9), Holger W. Auner(9), Valentina S. Caputo(8), Dragana Milojković(8), Richard Szydlo(7), Kikkeri N. Naresh(6), Alexia Katsarou(6), Franck Morschhauser(5), Hervé Tilly(5), Gilles Salles(5), Eduardo Olavarría(5), Stavroula Tsiara(5), Kanagaraju Ponnusamy(5), Nikolaos Trasanidis(5), Pam McKay(4), Michael Dickinson(4)